Overview

A Study to Evaluate Efficacy and Safety of HCP1401 for Stage 2 Hypertension Patients Not Controlled by HCP0605

Status:
Completed
Trial end date:
2016-09-01
Target enrollment:
Participant gender:
Summary
A phase 3 study to evaluate efficacy and safety of HCP1401
Phase:
Phase 3
Details
Lead Sponsor:
Hanmi Pharmaceutical Company Limited
Treatments:
Amlodipine
Chlorthalidone
Losartan